Cancer Information Highlights, May 8, 2019

National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
 
New from NCI
Fertility Preservation for Young Male Cancer Survivors
nurse talking to a little boy   A study in monkeys has shown promise in preserving the fertility of young boys being treated for cancer.
Immunotherapy Drug Shows Promise against HPV-Related Cancers
molecule   In a phase 1 clinical trial, an experimental immunotherapy drug shrank the tumors of some patients with advanced human papillomavirus (HPV)-related cancers.
Telephone-Based Rehab for People with Advanced Cancer

Learn about a study that found that a physical rehabilitation program delivered by telephone helped improve function and reduce pain for people with advanced cancer.
Genetic Testing for Inherited Cancer Susceptibility Syndromes

This page has been recently updated. Learn about genetic testing, which tests are available, and who should think about genetic testing for cancer risk.
Video—A Dialogue on Cancer Disparities, Prevention, and Research
snapshot from disparities facebook live   If you missed the live broadcast, you can now watch the recording of our Facebook Live event. Listen as subject matter experts discuss cancer disparities and the work being done to help reduce them.

PDQ Cancer Information Summary Updates
Childhood Liver Cancer Treatment

We’ve revised our childhood liver cancer summary to include radiofrequency ablation as a standard treatment option for progressive or recurrent hepatoblastoma.
Melanoma Treatment

We’ve revised our melanoma summary with updated information on targeted therapy used to treat this disease.
Drug Information Updates
New Drug for Bladder Cancer

We’ve added a new drug information summary for erdafitinib (Balversa). It was recently approved by the Food and Drug Administration to treat locally advanced or metastatic bladder cancer with certain changes involving the FGFR3 or FGFR2 gene. Erdafitinib is used in adults whose disease worsened during or after treatment with other chemotherapy.
 
Also of Interest
Organizations that Offer Cancer Support Services

If you need help finding support services for you or a loved one, search our database of more than 100 organizations that offer emotional, practical, and financial support services.
Cancer Treatment Research

Cancer treatment research is critical to progress against the disease. Learn about opportunities and challenges in cancer treatment research.